comprehensive molecular profiling lung adenocarcinoma
adenocarcinoma lung leading cause cancer death worldwide report molecular profiling resected lung adenocarcinomas using messenger rna microrna dna sequencing integrated copy number methylation proteomic analyses high rates somatic mutation seenmean mutations per megabase eighteen genes statistically significantly mutated including rit1 activating mutations newly described loss-of-function mga mutations mutually exclusive focal myc amplification egfr mutations frequent female patients whereas mutations rbm10 common males aberrations nf1 met erbb2 rit1 occurred % cases enriched samples otherwise lacking activated oncogene suggesting driver role events certain tumours dna mrna sequence tumour highlighted splicing alterations driven somatic genomic changes including exon skipping met mrna % cases mapk pik pathway activity measured protein level explained known mutations fraction cases suggesting additional unexplained mechanisms pathway activation data establish foundation classification investigations lung adenocarcinoma molecular pathogenesis
